Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
对 EGFR 抑制剂具有获得性耐药性的肺癌偶尔会出现 BRAF 基因突变，但缺乏 KRAS、NRAS 或 MEK1 突变
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:
doi:10.1073/pnas.1203530109
Kadoaki Ohashi, Lecia V Sequist, Maria E Arcila, Teresa Moran, Juliann Chmielecki, Ya-Lun Lin, Yumei Pan, Lu Wang, Elisa de Stanchina, Kazuhiko Shien, Keisuke Aoe, Shinichi Toyooka, Katsuyuki Kiura, Lynnette Fernandez-Cuesta, Panos Fidias, James Chih-Hsin Yang, Vincent A Miller, Gregory J Riely, Mar
